Losartan potassium recall 2019
[PDF File]Losartan products under recall - Updated February 22, 2019
https://info.5y1.org/losartan-potassium-recall-2019_1_a82015.html
May 03, 2019 · Drug Recall DATE OF RECALL: May 3, 2019 DRUG NAME: Losartan Potassium RECALLING FIRM: Vivimed Life Sciences Pvt Ltd REASON FOR RECALL: This recall was issued due to the detection of an impurity – N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) – that is above the US Food & Drug Administration’s interim acceptable exposure limit of 9.82 ppm.
[PDF File]Losartan Potassium tablets May 3, 2019 acid (NMBA) Impurity
https://info.5y1.org/losartan-potassium-recall-2019_1_f068ee.html
Drug recall notice for Losartan Potassium and Losartan Potassium Hydrochlorothiazide tablets May 3, 2019 Updated: Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium/Hydrochlorothiazide Tablets, USP
[PDF File]Camber Pharmaceuticals – Recall of losartan
https://info.5y1.org/losartan-potassium-recall-2019_1_b4a76c.html
Class 3 Recall: Using the drug is not likely to cause adverse health consequences. NOTE: This is not a complete list of all recalls. Please see FDA.gov >Drugs>Drug Safety and Availability> Drug Recalls for additional information. Losartan Potassium tablets 02315564503 02315564509 02315564510 02315564509 02315564603 02315564609 02315564610
Development and validation of a RapidFire-MS/MS method …
Camber Pharmaceuticals – Recall of losartan • On February 28, 2019, the FDA announced the voluntary, consumer-level recall of several lots of Camber Pharmaceuticals’ losartan tablets due to the detection of trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA), a possible process impurity or contaminant in an active ...
[PDF File]Drug Recall - AllWays Health Partners
https://info.5y1.org/losartan-potassium-recall-2019_1_00ea96.html
Losartan potassium is used to treat high blood pressure. From November 2018 to March 2019, FDA alerted patients and health care professionals to the recall of losartan potassium
[PDF File]Drug Recall List - Blue Cross Blue Shield of Michigan
https://info.5y1.org/losartan-potassium-recall-2019_1_f0a853.html
Aug 07, 2019 · Revision: 08/07/2019 Page: 1 of 5 Losartan (potassium salt) SAFETY DATA SHEET Supersedes Revision: 01/29/2015 according to Regulation (EC) No. 1907/2006 as amended by (EC) No. 2015/830 and US OSHA HCS 2015
Losartan Recall Expanded for Cancer-Causing Impurity
Jun 26, 2019 · Macleods Pharmaceuticals Limited is recalling 32 lots of the popular blood pressure drug losartan after discovering trace amounts of a probable carcinogen. The recalled losartan and potassium ...
[PDF File]Drug recall notice for Losartan Potassium and Losartan ...
https://info.5y1.org/losartan-potassium-recall-2019_1_d4208d.html
BX35C020 05/2019 BX35C049 08/2019 BX35C022 05/2019 BX35C023 05/2019 Losartan products under recall - Updated February 22, 2019 Losartan Potassium 100mg Tablets, 1000 count bottle 13668-115-10 13668-409-90 Losartan Potassium 50mg Tablets, 90 count bottle Losartan Potassium and Hydrochlorothiazide (HCTZ) 100mg/12.5mg Tablets, 90 count bottle ...
Losartan recall 2019: Blood pressure drug recalled for ...
Drug recall notice for Losartan Potassium tablets May 3, 2019 Vivimed Life Sciences Pvt Ltd Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg, 50 mg and 100 mg Tablets, USP Due to the Detection of Trace Amounts of N-Nitroso-N-methyl-4-aminobutyric
[PDF File]SAFETY DATA SHEET Page: 1 of 5 Losartan (potassium salt ...
https://info.5y1.org/losartan-potassium-recall-2019_1_666453.html
GX0135 Aug 2020 1 x 28 07/02/2019 Further to previous recalls of Valsartan and Irbesartan containing products, which were potentially contaminated with N-nitrosodimethylamine (NDMA) or N-nitrosodiethylamine (NDEA), we have become aware of products containing Losartan Potassium that are contaminated with a different nitrosamine, N-
Nearby & related entries:
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.